NABL launches new Medical Application Portal for ISO 15189:2022 applicant laboratories

IMT News Desk
IMT News Desk
· 2 min read

Portal to enhance ease, efficiency and transparency in accreditation process

The National Accreditation Board for Testing and Calibration Laboratories (NABL), a constituent board of the Quality Council of India (QCI), launched its new Medical Application Portal designed for ISO 15189:2022 applicant laboratories. The online portal was unveiled during a virtual event titled ‘GOING LIVE, marking a major step in NABL’s mission to enhance ease, efficiency, and transparency in the accreditation process.

The newly launched NABL Medical Application Portal has been reimagined to mirror the real-world operations of medical laboratories, offering a streamlined application process with improved user experience, reduced timelines, and greater accuracy. The portal introduces several enhancements, including a restructured application flow, standardised templates, a comprehensive pre-registration checklist, an intuitive interface, and a multi-user access feature that enables laboratories to assign multiple users with distinct access rights. This is expected to accelerate data entry, enhance oversight, and ensure accountability throughout the accreditation lifecycle.

Chairperson, QCI, Jaxay Shah said that with the new NABL Medical Application Portal, tasks that once took weeks or even months can now be completed within just two to three hours. He added that this marks one of the most significant disruptions in the quality ecosystem and that the same approach will now be extended to other sectors, embedding technology-driven efficiency, innovation, and responsiveness at the heart of India’s quality journey.

Chairperson, NABL, Dr Sandip Shah, said that the portal is a transformational step towards making the accreditation process more transparent and efficient. He added that with multi-user access and simplified features, NABL is enhancing ease of doing business for laboratories and reinforcing its commitment to India’s quality ecosystem.

The initiative is expected to benefit hundreds of medical laboratories across India, providing them with an intuitive, transparent, and efficient digital platform for accreditation under ISO 15189:2022. The launch event included a live demonstration of the portal, a walkthrough of its features, and an interactive Q&A session with participants from medical laboratories nationwide.

PIB

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk